Workflow
Stock Offering
icon
Search documents
Sable Offshore Under Federal And SEC Investigation—The Plot Thickens
Benzinga· 2026-02-03 20:45
Sable Offshore Corp. (NYSE:SOC) on Tuesday disclosed in a regulatory filing for a $250 million stock offering, that both the U.S. Securities and Exchange Commission (SEC) and federal prosecutors in New York have issued subpoenas for company documents.The core issues involve allegations that the company shared sensitive data with specific high-profile investors, including professional golfer Phil Mickelson, while keeping others in the dark. Benzinga reached out to Sable Offshore for comment, but did not rece ...
What's Going On With Offerpad Stock Tuesday? - Offerpad Solutions (NYSE:OPAD)
Benzinga· 2026-01-13 15:41
Core Viewpoint - Offerpad Solutions Inc. has announced a stock sale agreement with institutional buyers, leading to a significant drop in its stock price [1][4] Group 1: Stock Offering Details - The company has entered into a securities purchase agreement for a registered direct offering of 10 million shares of common stock priced at $1.80 each, resulting in gross proceeds of approximately $18 million before fees [1] - The offering is expected to close on or about January 13, 2026, pending customary closing conditions [2] Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for general working capital, supporting growth initiatives, enhancing inventory optimization, and strengthening the company's balance sheet [2] Group 3: Company Operations - Offerpad operates a technology-driven platform for residential real estate transactions, aiming to simplify home buying and selling through digital solutions [3] - A.G.P./Alliance Global Partners is serving as the sole placement agent for the offering, and the company will file a prospectus supplement with the U.S. Securities and Exchange Commission [3]
Fortress Biotech(FBIO) - Prospectus
2025-12-15 22:53
As filed with the Securities and Exchange Commission on December 15, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FORTRESS BIOTECH, INC. (Exact name of registrant as specified in its charter) Delaware 20-5157386 (State or other jurisdiction of incorporation or organization) 1111 Kane Concourse, Suite 301 Bay Harbor Islands, FL 33154 (Address, including zip code, and telephone number, includ ...
Manulife Financial Corporation Prices U.S. Public Offering of Senior Notes
Prnewswire· 2025-12-02 22:52
Core Points - Manulife Financial Corporation has priced a public offering of U.S.$1,000,000,000 aggregate principal amount of 4.986% senior notes due 2035 at a public offering price of 100% [1] - The net proceeds from the sale of the notes will be used for general corporate purposes, which may include future refinancing requirements [2] - The offering is managed by BofA Securities, Citigroup Global Markets, J.P. Morgan Securities, and Morgan Stanley [2] Company Overview - Manulife Financial Corporation is a leading international financial services provider with global headquarters in Toronto, Canada, operating as Manulife in Canada, Asia, and Europe, and as John Hancock in the United States [5] - The company provides financial advice and insurance for individuals, groups, and businesses, and offers global investment, financial advice, and retirement plan services [5] - As of the end of 2024, Manulife had over 37,000 employees, more than 109,000 agents, and served over 36 million customers [5]
Libera Gaming Operations(LBRJ) - Prospectus(update)
2025-12-02 22:21
As filed with the U.S. Securities and Exchange Commission on December 2, 2025 Registration No. 333-277981 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Pre-Effective Amendment No. 15 to Form F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Libera Gaming Operations, Inc. (Exact name of Registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) (State or other jurisdiction of incorporation or organization) (Primary Standard Indus ...
GFL Environmental Inc. Announces Pricing of Secondary Offering by Selling Shareholders and Agreement to Repurchase 1,275,000 Subordinate Voting Shares in Secondary Offering
Prnewswire· 2025-11-21 11:45
Core Points - GFL Environmental Inc. announced the pricing of a secondary offering of 16,611,295 subordinate voting shares at a public offering price of US$45.15 per share [1] - The company has agreed to purchase for cancellation a total of 1,275,000 shares from RBC Dominion Securities Inc. as part of the offering [2] - The shares will be offered in all provinces and territories of Canada through a prospectus supplement to the company's base shelf prospectus [3] Offering Details - The offering is being underwritten by RBC Capital Markets, LLC in the United States and RBC Dominion Securities Inc. in Canada [1] - The prospectus supplement will be accessible on or about November 24, 2025, through SEDAR+ [5] - GFL has filed a registration statement on Form F-10 with the SEC for the offering [6] Company Background - GFL is headquartered in Vaughan, Ontario, and is the fourth largest diversified environmental services company in North America [8] - The company provides a comprehensive line of solid waste management services across Canada and in 18 U.S. states [9] - GFL employs approximately 15,000 individuals across its organization [9]
OGE Energy Corp. Prices Public Offering of 8,023,256 Shares of Common Stock
Prnewswire· 2025-11-21 04:50
Core Viewpoint - OGE Energy Corp. has announced a public offering of 8,023,256 shares of common stock at a price of $43.00 per share, aiming to raise approximately $345 million to fund capital expenditures and other corporate purposes [1][10]. Offering Details - The offering consists of 8,023,256 shares, with 4,011,628 shares being sold directly by OGE Energy Corp. and the remaining shares sold by forward sellers [1]. - Underwriters, including Morgan Stanley and J.P. Morgan, have been appointed to manage the offering, with an option to purchase an additional 1,203,488 shares [2]. - The expected closing date for the offering is around November 24, 2025, subject to customary conditions [2]. Forward Sale Agreements - OGE Energy Corp. has entered into forward sale agreements with Morgan Stanley and J.P. Morgan, agreeing to sell the same number of shares borrowed from third parties at an initial forward sale price of $41.71 per share [3]. - Settlement of these forward sale agreements is anticipated to occur within 18 months following the offering's completion [3]. Use of Proceeds - The net proceeds from the direct sale of shares will be allocated to general funds, capital expenditures, and debt repayment or refinancing [4]. - OGE Energy Corp. will not receive initial proceeds from shares sold by forward sellers but intends to utilize proceeds from the settlement of forward sale agreements for similar purposes [4]. Company Overview - OGE Energy Corp. is the parent company of OG&E, serving approximately 910,000 customers in Oklahoma and western Arkansas, focusing on the generation, transmission, distribution, and sale of electric energy [6].
American Healthcare REIT Announces Public Offering of Common Stock
Prnewswire· 2025-11-20 21:01
Core Viewpoint - American Healthcare REIT, Inc. has initiated an underwritten public offering of 8,100,000 shares of its common stock, with RBC Capital Markets serving as the underwriter [1] Offering Details - The company plans to enter into a forward sale agreement with RBC Capital Markets for the 8,100,000 shares, with an option for the underwriter to purchase an additional 1,215,000 shares [2] - If the underwriter exercises the option, the total shares could increase to 9,315,000, and an additional forward sale agreement will be established [3] Forward Sale Agreement - The forward purchaser is expected to borrow and sell the shares to the underwriter, but is not obligated to do so if certain conditions are not met [3] - The company will issue shares to the underwriter equal to any shares not delivered by the forward purchaser, reducing the number of shares under the forward sale agreement accordingly [4] Proceeds and Use of Funds - The company will not receive proceeds from the forward purchaser's sale of shares, but expects to contribute any net proceeds from the settlement to its operating partnership for general corporate purposes [5] Regulatory Compliance - All shares will be offered under the company's effective shelf registration statement filed with the SEC, and a preliminary prospectus supplement will be made available [6]
Nuvalent Announces Pricing of Public Offering of Common Stock
Prnewswire· 2025-11-19 04:50
Core Viewpoint - Nuvalent, Inc. has announced a public offering of Class A common stock priced at $101.00 per share, aiming to raise approximately $500 million before expenses [1][2]. Group 1: Offering Details - The company is selling 4,950,496 shares in the offering, with the expected closing date on November 20, 2025, pending customary closing conditions [1]. - Selling stockholders have granted underwriters a 30-day option to purchase an additional 742,574 shares at the public offering price [2]. - J.P. Morgan, Jefferies, TD Cowen, and Cantor are acting as joint book-running managers for the offering [3]. Group 2: Regulatory Information - The shares are being offered under an automatically effective shelf registration statement filed with the SEC on March 16, 2023 [4]. - A preliminary prospectus supplement has been filed with the SEC, and a final prospectus will also be filed [4]. Group 3: Company Overview - Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for cancer, particularly for kinase targets [6]. - The company aims to create innovative small molecules that can overcome resistance and minimize adverse events, with a pipeline targeting ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer [6].
Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M
Prnewswire· 2025-11-13 21:05
Core Points - Biohaven Ltd. has successfully closed its underwritten public offering of 26,833,334 common shares, raising approximately $200 million in gross proceeds, which includes the full exercise of the underwriters' option to purchase an additional 3,500,000 shares at a public offering price of $7.50 per share [1][7] - The offering was upsized from an initially announced size of $150 million to $175 million, indicating strong demand for the shares [1] - The net proceeds from the offering will be used for general corporate purposes, although specific allocations have not been detailed [1] Company and Industry Summary - Biohaven Ltd. is a global clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies for a wide range of rare and common diseases [1][8] - The offering was managed by a consortium of financial institutions, including J.P. Morgan, Goldman Sachs & Co. LLC, Leerink Partners, TD Cowen, and Cantor Fitzgerald [2] - The shares were issued under an effective shelf registration statement on Form S-3, allowing for streamlined access to capital markets [4]